Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/OCF ratio is N/A as of 2026-10-06T19:27:40.457Z.
Calculation as of: 2026-10-06T19:27:40.457Z.
Quote observation: 2026-10-06T19:24:32.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 8d1468b7a76ea597d68349990a611a16a2ef6f087c77b10e193910d6856baa6d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/OCF RATIO
N/A
Market Cap
$30.25M
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PRICE/OCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $29.37M | N/A | N/A | N/A | N/A |
| GridAI Technologies Corp. (GRDX)vs › | $29.24M | N/A | N/A | N/A | N/A |
| BeyondSpring Inc. (BYSI)vs › | $29.61M | N/A | N/A | N/A | N/A |
| Tevogen Bio Holdings Inc. (TVGN)vs › | $28.94M | N/A | N/A | N/A | N/A |
| Context Therapeutics Inc. (CNTX)vs › | $29.59M | N/A | N/A | N/A | N/A |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $30.25M | N/A | N/A | N/A | N/A |
| OneMedNet Corporation (ONMD)vs › | $29.27M | N/A | 2.80 | 2.80 | 2.80 |
| CervoMed Inc. (CRVO)vs › | $30.37M | N/A | N/A | N/A | N/A |
| SCYNEXIS, Inc. (SCYX)vs › | $30.81M | N/A | 4.37 | 4.37 | 4.37 |
| Rockwell Medical, Inc. (RMTI)vs › | $30.63M | 10.57 | 10.58 | 13.01 | 13.01 |
P/OCF Ratio
N/A
P/FCF Ratio
N/A
P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
